ELIZABETH MEADOR: Open Payments
NPI 1619067055 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 34 payments from 14 companies in 2025. Trend: 2023 $1,160 · 2024 $976 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $220 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
| LEO Pharma Inc. | 3 | $49 |
| GENZYME CORPORATION | 2 | $48 |
| Incyte Corporation | 2 | $46 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $45 |
| Organon LLC | 1 | $38 |
| Lilly USA, LLC | 1 | $29 |
| Almirall LLC | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $24 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, Cabtreo, VTAMA, EBGLYSS, ADBRY, RINVOQ.
Industry payments across FL — which companies pay providers there.
